Drug Designing & Research

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modelling techniques. This type of modelling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.

Chemicals (Drug Designing), the building blocks of the world, represent one of the oldest and largest industries globally. The global market of chemistry is now trending towards quality products and processes with least impact on environment. The global chemical industry is estimated to be US $2.4 trillion dollars contributing significantly in the market growth of US, Europe, and Middle East Countries. The demand for chemical products is highest in the Asia, Japan and Korea. The annual US chemical output alone is US $750 billion dollars. The global chemical industry market is expected to grow at a CAGR of 3.7% by 2020.

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modelling techniques. This type of modelling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.

Chemicals (Drug Designing), the building blocks of the world, represent one of the oldest and largest industries globally. The global market of chemistry is now trending towards quality products and processes with least impact on environment. The global chemical industry is estimated to be US $2.4 trillion dollars contributing significantly in the market growth of US, Europe, and Middle East Countries. The demand for chemical products is highest in the Asia, Japan and Korea. The annual US chemical output alone is US $750 billion dollars. The global chemical industry market is expected to grow at a CAGR of 3.7% by 2020.

  • Types of Drug Designing
  • Ligand Based
  • Strucure Based
  • Binding Site Identification
  • Case Studies
  • Rational Drug Discovery
  • Computer Aided Drug Designing

Related Conference of Drug Designing & Research

Drug Designing & Research Conference Speakers